Efficacy of Once-Nightly Sodium Oxybate in Patients with Narcolepsy: Post Hoc Analyses of Sensitivity, Effect Size, and Numbers Needed to Treat from the Phase 3 REST-ON Trial
Authors
Thomas Roth (ORCID: https://orcid.org/0000-0001-8309-4134)
Clete A. Kushida (ORCID: https://orcid.org/0000-0002-9430-3752)
Jennifer Gudeman (ORCID: https://orcid.org/0000-0002-7375-5020)
Efficacy of Once-Nightly Sodium Oxybate in Patients with Narcolepsy: Post Hoc Analyses of Sensitivity, Effect Size, and Numbers Needed to Treat from the Phase 3 REST-ON Trial
Thomas Roth, Clete A. Kushida, Jennifer Gudeman, Michael J. Thorpy
Citations
1 citations
Journal
CNS Drugs
Topics
Sleep and Wakefulness Research
Field-Weighted Citation Impact (FWCI)
1.43
article
Efficacy of Once-Nightly Sodium Oxybate in Patients with Narcolepsy: Post Hoc Analyses of Sensitivity, Effect Size, and Numbers Needed to Treat from the Phase 3 REST-ON Trial
Thomas Roth, Clete A. Kushida, Jennifer Gudeman, Michael J. Thorpy
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
CNS DrugsVol. 39(S1)
Institutions
Albert Einstein College of Medicine (US), University of Chester (GB), Henry Ford Health System (US), Stanford Medicine (US), Stanford University (US)